PAT Implementation Poses Challenge Of Industry-FDA Collaboration
Executive Summary
Collaborating with FDA will be the greatest challenge for industry in implementing the process analytical technology component of FDA's drug quality initiative, AstraZeneca Chemistry, Manufacturing & Controls Group Director Robert Timko said
You may also be interested in...
Novartis Sets Out On The Critical Path; Will Others Follow?
Novartis' announcement of research collaborations with FDA is one of the first tangible outcomes of the agency's Critical Path initiative
Novartis Sets Out On The Critical Path; Will Others Follow?
Novartis' announcement of research collaborations with FDA is one of the first tangible outcomes of the agency's Critical Path initiative
Industry PAT Initiatives Mirror FDA’s Cross-Disciplinary Approach
FDA's effort to create a cross-functional, organization-wide approach to advance process analytical technology from a regulatory vantage point is being mirrored by industry as companies seek to convert PAT theory into practice